Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery…. »
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Administration… »
While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant money committed…. »
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard announced a new initiative yesterday to accelerate technologies designed to identify, assess, develop, and scale treatments to the COVID-19 epidemic. The… »
Toronto-based startup Luna Design and Innovation is a prime example of the kind of space company that is increasingly starting up to take advantage of the changing economics of the… »
For nearly fifteen years LanzaTech has been developing a carbon capture technology that can turn waste streams into ethanol that can be used for chemicals and fuel. Now, with $72… »
Okay do you know how we can taste things and that was pretty special? It’s not special anymore, because researchers at UC Davis working with colleagues Carnegie Mellon have developed… »
Jason Rowley Contributor Jason Rowley is a venture capital and technology reporter for Crunchbase News. More posts by this contributor Ride-hailing, bike and scooter companies probably raised less money than… »
As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And few people are more familiar… »
Jeff Farrah Contributor Share on Twitter Jeff Farrah is the general counsel of the National Venture Capital Association. Big changes in DC could mean that more startups will need the… »
Continuing its quest to become the Amazon Web Services for biomanufacturing, href=”http://ginkgobioworks.com/”>Ginkgo Bioworks has launched a new spinoff called Motif Ingredients with $90 million in funding to develop proteins that… »
The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a new path for CRISPR gene… »
Grim milestone comes as Joe Biden’s incoming chief of staff says 500,000 could die in US next month; EU states raise concerns about Pfizer slowdown German vaccine officials forced to… »
All foreign arrivals will also have to quarantine in toughening of measures in response to new strains Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has announced… »
